Procter & Gamble (NYSE:PG – Get Free Report) is projected to announce its Q4 2026 results before the market opens on Wednesday, July 29th. Analysts expect Procter & Gamble to post earnings of $1.41 per share and revenue of $21.3819 billion for the quarter. Procter & Gamble has set its FY 2026 guidance at 6.830-7.090 EPS. Parties can find conference call details on the company’s upcoming Q4 2026 earning report for the latest details on the call scheduled for Wednesday, July 29, 2026 at 8:30 AM ET.
Procter & Gamble (NYSE:PG – Get Free Report) last announced its earnings results on Friday, April 24th. The company reported $1.59 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.56 by $0.03. Procter & Gamble had a net margin of 19.16% and a return on equity of 32.00%. The company had revenue of $21.23 billion during the quarter, compared to analysts’ expectations of $21.52 billion. During the same quarter in the previous year, the business posted $1.54 earnings per share. The firm’s quarterly revenue was up 7.4% compared to the same quarter last year. On average, analysts expect Procter & Gamble to post $7 EPS for the current fiscal year and $7 EPS for the next fiscal year.
Procter & Gamble Stock Down 0.7%
Shares of NYSE PG opened at $148.12 on Wednesday. The firm’s 50-day moving average is $147.00 and its two-hundred day moving average is $148.63. The company has a market capitalization of $344.91 billion, a PE ratio of 21.66, a price-to-earnings-growth ratio of 7.42 and a beta of 0.39. Procter & Gamble has a 12-month low of $137.62 and a 12-month high of $167.25. The company has a debt-to-equity ratio of 0.44, a current ratio of 0.73 and a quick ratio of 0.53.
Procter & Gamble Dividend Announcement
Wall Street Analysts Forecast Growth
A number of research firms recently issued reports on PG. BMO Capital Markets upped their target price on Procter & Gamble from $169.00 to $170.00 and gave the company an “outperform” rating in a research note on Monday, June 29th. Raymond James Financial dropped their price target on Procter & Gamble from $175.00 to $170.00 and set an “outperform” rating for the company in a research report on Tuesday, April 14th. UBS Group boosted their price target on Procter & Gamble from $166.00 to $172.00 and gave the stock a “buy” rating in a report on Monday, April 27th. Rothschild & Co Redburn decreased their price objective on Procter & Gamble from $157.00 to $155.00 and set a “neutral” rating on the stock in a research note on Monday, April 27th. Finally, Jefferies Financial Group lifted their price objective on Procter & Gamble from $177.00 to $179.00 and gave the stock a “buy” rating in a research report on Friday, June 26th. Twelve equities research analysts have rated the stock with a Buy rating and nine have issued a Hold rating to the stock. According to MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and an average price target of $161.74.
Check Out Our Latest Report on Procter & Gamble
Procter & Gamble News Summary
Here are the key news stories impacting Procter & Gamble this week:
- Positive Sentiment: Procter & Gamble is expanding manufacturing in Egypt to use the country as a hub for exports into Gulf and African markets, which could improve supply-chain efficiency and support longer-term international growth. Procter & Gamble (PG) Expands Egypt Manufacturing To Serve Gulf And African Markets
- Positive Sentiment: Several articles frame PG as a defensive “safe haven” and a strong dividend stock, which may be attracting investors looking to rotate away from higher-volatility AI names and into steadier consumer staples. As the AI Selloff Worsens, Time-Tested Procter Gamble Stock Could Be the Biggest Winner
- Positive Sentiment: PG is also being compared favorably on value and dividend appeal versus other consumer-staples names, reinforcing the view that it remains a high-quality holding for long-term income investors. NWL vs. PG: Which Stock Is the Better Value Option?
Institutional Trading of Procter & Gamble
Several institutional investors have recently made changes to their positions in PG. State Street Corp boosted its holdings in Procter & Gamble by 1.0% in the fourth quarter. State Street Corp now owns 101,618,926 shares of the company’s stock valued at $14,563,008,000 after acquiring an additional 984,102 shares during the last quarter. Price T Rowe Associates Inc. MD raised its holdings in shares of Procter & Gamble by 3.8% in the 4th quarter. Price T Rowe Associates Inc. MD now owns 29,612,826 shares of the company’s stock worth $4,243,815,000 after purchasing an additional 1,091,091 shares during the period. Charles Schwab Investment Management Inc. raised its holdings in shares of Procter & Gamble by 6.3% in the 4th quarter. Charles Schwab Investment Management Inc. now owns 18,779,055 shares of the company’s stock worth $2,691,228,000 after purchasing an additional 1,120,313 shares during the period. Dimensional Fund Advisors LP increased its position in Procter & Gamble by 5.7% during the 4th quarter. Dimensional Fund Advisors LP now owns 11,497,636 shares of the company’s stock worth $1,647,809,000 after purchasing an additional 619,934 shares in the last quarter. Finally, Amundi increased its position in Procter & Gamble by 26.3% during the 3rd quarter. Amundi now owns 10,682,455 shares of the company’s stock worth $1,606,748,000 after purchasing an additional 2,222,560 shares in the last quarter. 65.77% of the stock is owned by hedge funds and other institutional investors.
Procter & Gamble Company Profile
Procter & Gamble (NYSE: PG) is a multinational consumer goods company headquartered in Cincinnati, Ohio. Founded in 1837 by William Procter and James Gamble, P&G has grown into one of the world’s largest producers of branded consumer packaged goods. The company focuses on developing, manufacturing and marketing a broad portfolio of household and personal care products sold to consumers and retailers worldwide.
P&G’s product offering spans several core business categories, including Beauty, Grooming, Health Care, Fabric & Home Care, and Baby, Feminine & Family Care.
Read More
- Five stocks we like better than Procter & Gamble
- Confidence Is Back, But Earnings Show the Consumer Is Being Picky
- AeroVironment’s Stock Is Down, But Drone Demand Is Taking Off
- 3M’s Redemption Arc: Can Q2 Earnings Change the Narrative?
- 3 Photonics Companies Making Quantum Tech Possible
Receive News & Ratings for Procter & Gamble Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Procter & Gamble and related companies with MarketBeat.com's FREE daily email newsletter.
